Medivir announces data from two phase III studies with Simeprevir in hepatitis C subpopulations - HCV/HIV co-infected and genotype 4 infected patients Stockholm, Sweden - Medivir AB today announced preliminary data from two phase III studies conducted by Janssen R&D Ireland evaluating simeprevir in genotype 4 chronic hepatitis C in adult patients ... (more)
http://www.drugs.com/clinical_trials/medivir-announces-data-two-phase-iii-studies-simeprevir-hepatitis-c-subpopulations-16237.html?
http://www.drugs.com/clinical_trials/medivir-announces-data-two-phase-iii-studies-simeprevir-hepatitis-c-subpopulations-16237.html?
No comments:
Post a Comment